Document is current
Any future updates will be listed below
-
Authors
Łabuz, Grzegorz
Güngör, Helin
Auffarth, Gerd U. http://orcid.org/0000-0002-6927-5251
Yildirim, Timur M.
Khoramnia, Ramin
-
Funding
Funding for this research was provided by:
Klaus Tschira Stiftung
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 7 April 2023
Accepted: 18 November 2023
First Online: 12 December 2023
Declarations
:
: The study procedures adhered to the tenets of the Declaration of Helsinki and were conducted in compliance with Ethical Committee's approval (S-392/2011) granted by Heidelberg Medical Faculty's review board. Informed consent was obtained from all participants.
: Not applicable.
: G. U. Auffarth and R. Khoramnia report grants, personal fees, nonfinancial support and consulting fees from Johnson and Johnson Vision Care, Inc. and Alcon Laboratories, Inc., grants, personal fees, and nonfinancial support from Hoya Corp., Kowa Co. Ltd., Oculentis/Teleon, Carl Zeiss Meditec AG, Santen and SIFI, grants and personal fees from Bausch + Lomb, Biotech and OCULUS Optikgeräte GmbH, and grants from AcuFocus, Inc., Eyebright, Hanita, Ophtec, Ophthalmopro, Physiol, Rayner and VSY, outside the submitted work. G. Łabuz, H. Güngör and T. M. Yildirim declare no potential conflict of interest. The University of Heidelberg holds a pending patent application (no. EP22187235) entitled "Lens with extended depth of focus by inducing an excess of longitudinal chromatic aberration," with G.U. Auffarth and G. Łabuz as inventors.
